Investors

Welcome to the Mendus investor page. Mendus is listed on NASDAQ Stockholm under the ticker symbol IMMU.
Secured Rights Issue 2017
On this page, you will find all relevant information that are published in connection with Immunicums’ proposed Rights Issue.
Press release
The Board of Directors of Immunicum AB (publ) Resolves on a 90% Secured Rights Issue of up to SEK 223 Million to Finance Further Development of its Portfolio
2 November 2017
Download PDF
Press release
Notice to Attend the Extraordinary General Meeting of Immunicum
2 November 2017
Download PDF
Press release
Press release
Immunicum AB (publ) Announces the Outcome of the Rights Issue
29 December 2017
Download PDF
Prospectus
5 December 2017
Download Prospectus PDF
Contact
Telephone
+46 (0)8 732 8400
info@immunicum.com

Head Office
Västra Trädgårdsgatan 15
111 53 Stockholm
Sweden

R&D Offices
Emmy Noetherweg 2K
2333 BK Leiden
The Netherlands
